Patent details

91271 Product Name: "natalizumab et ses dérivés pharmaceutiquement acceptables ( TYSABRI®)"

Basic Information

Publication number:
91271
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP959087412
Legal Status:
Expired
Application number:
91271
First applicant's nationality:
United States (US)
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
15/03/2017
SPC Extension Agent Name:
Office FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
16/11/2018
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/06/346/001
Marketing Authorization Type:
Marketing Authorization Date:
27/06/2006
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
02/08/2006
First Marketing Authorization date:
27/06/2006
Grant date:
02/10/2006
Activation date:
25/01/2015
Publication date:
02/10/2006
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/01/2020
SPC Extension Expiration:
25/07/2020
Rejection date:
Withdrawal date:

Owner

From:
03/05/2017
 
 

Name:
Biogen MA, Inc.
Address:
225 Binney Street, 02142, Cambridge, MA, United States (US)

History of Owners

From:
06/11/2013
To:
03/05/2017

Name:
BIOGEN IDEC MA INC.
Address:
CAMBRIDGE CENTER 14, CAMBRIDGE, MA 02142, United States (US)

From:
06/11/2013
To:
06/11/2013

Name:
BIOGEN IDEC INTERNATIONAL HOLDING LTD.
Address:
CANON'S COURT, 22 VICTORIA STREET, HAMILTON HM EX, Bermuda (BM)

Name:
ELAN PHARMACEUTICALS , INC.
Address:
300 TECHNOLOGY SQUARE, THIRD FLOOR, CAMBRIDGE, MA 02139, United States (US)

From:
02/08/2006
To:
05/11/2013

Name:
ELAN PHARMACEUTICALS, INC.
Address:
GATEWAY BOULEVARD 800, SOUTH SAN FRANCISCO, CA 94080, United States (US)

Agent

1

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
06/11/2013
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

2

Name:
OFFICE FREYLINGER S.A.
From:
02/08/2006
Address:
ROUTE D'ARLON 234, PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
05/11/2013

Inventor

1

Name:
SALDANHA Jose
Address:
United Kingdom (GB)

2

Name:
JONES Tarran S.
Address:
United Kingdom (GB)

3

Name:
BENDIG Mary M.
Address:
United Kingdom (GB)

4

Name:
YEDNOCK Theodore A.
Address:
United States (US)

5

Name:
LEGER Olivier J.
Address:
United Kingdom (GB)

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
SPCX2
Bulletin edition number:
2018/13
Publication date:
13/12/2018
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

3

Bulletin Heading:
SPCX1
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section G : Applications for extensions for pediatric use – I1E publication

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20170000134A
Date Registered:
03/05/2017
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Biogen MA, Inc.
Address:
225 Binney Street, 02142, Cambridge, MA, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
30/01/2019
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
ENVOY INTERNATIONAL LIMITED
Filing date Document type Number of pages
15/03/2017 Application Form 4
23/03/2017 FNET_DC_FRONTPAGE 1
16/11/2018 Certificate 1
16/11/2018 Publication 1
23/03/2017 Publication 1
03/05/2017 Request For Change 1
16/11/2018 Outgoing Correspondence 1
04/05/2017 Outgoing Correspondence 1